THERMO FISHER SCIENTIFIC INC.
TMONYSEDiagnostics & Research • Healthcare
Comprehensive AI Analysis
Strategic AI Analysis for TMO
Checking whether the approved providers contain enough current financial data for a reliable report.
Summary
Source-linked company research for TMO
Factor Scorecard
Mechanical 0-100 composites from the displayed inputs. Bands and colours are numerical aids, not security ratings or investment actions.
Latest results at a glance
Insights from the latest company results and reports · filed 23 Jul 2026
Q2 Revenue and EPS Growth
Second-quarter 2026 revenue grew 10% to $11.99 billion, with organic revenue growth of 5% compared to the same quarter in 2025.
Earnings Exceed Consensus
Reported adjusted EPS of $6.03 per share for the quarter ended June 30, 2026, exceeded the same-quarter consensus estimate of $5.71.
Operating Margin Expansion
Adjusted operating margin reached 22.8% in the second quarter of 2026, up from 21.9% in the second quarter of 2025.
Capital Return Coverage
Free cash flow of $6.293 billion in the fiscal year ended 2025 was 2.10 times the $3 billion in common stock repurchases.
Price Chart
NYSE:TMO via TradingView
Loading TradingView chart...
Overview
Quarterly income statement data isn't available for this company.
No Data
No annual financial data available.
Financial Fundamentals
Growth, quality, valuation, cash generation, and balance-sheet strength.
Growth
TTM revenue plus current, long-term, forward, and accelerating top-line trends.
Earnings
Trailing EPS, current EPS growth, long-term compounding, surprise, and forward expectations.
Profitability
TTM margin and return metrics that reflect pricing power and business quality.
Cash Flow
TTM free cash flow, growth, margin, and operating-cash conversion quality.
Valuation
Metrics ranked by issuer type, financial state, and input quality.
Forward P/E
Forward P/E is the primary lens because positive expected earnings make the next operating period directly assessable.
Financial Health
Latest-quarter liquidity and leverage checks plus TTM interest coverage.
Shareholder Signals
Capital returns and dilution checks sourced from statements and insider filings.
Peer Comparison
| Ticker | Price | Mkt Cap | EV/EBITDA | Fwd P/E | Rev Growth | Gross Margin | FCF Yield |
|---|---|---|---|---|---|---|---|
TMOTHERMO FISHER SCIENTIFIC INC. | $622.18 | $230.0B | 24.7x | 24.8x | +7.2% | — | 3.2% |
Company Profile
About the Company
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Next Earnings Date
Oct 21, 2026
Loading latest news...